DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

Jabbour E, Kantarjian H, Ravandi F. et al.
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.

Lancet Oncol 2015;
16 (15) 1547-1555

Download Bibliographical Data

Access:
Access: